- socially bharat
- November 5, 2024
Lytix Biopharma – Update from licensing partner Verrica Pharmaceuticals
Oslo, November 5th, 2024: Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, refers
Oslo, November 5th, 2024: Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer treatment, refers
Seeking to improve the cardiovascular safety of pharmaceuticals, the National Toxicology Program (NTP) partnered with the nonprofit Health and Environmental Sciences Institute (HESI) and the
In a follow-up to the suspension of the licence of Mumbai-based pharmaceutical company ENTOD Pharmaceuticals by the Drugs Control General of India (DCGI) last month,
Saint-Prex, Switzerland: This milestone represents significant progress in Ferring’s manufacturing capabilities to meet anticipated growth in demand for Adstiladrin®